Contribution of Tumour and Immune Cells to PD-L1 Expression As a Predictive Biomarker in Metastatic Triple-Negative Breast Cancer: Exploratory Analysis from KEYNOTE-119
JOURNAL OF PATHOLOGY CLINICAL RESEARCH(2024)
关键词
pembrolizumab,PD-L1,triple-negative breast cancer
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要